RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Casma Therapeutics

Casma Therapeutics

With deep expertise in cellular degradation biology, Casma is advancing targeted therapies for neurodegeneration and beyond.

Health and bio
Latest funding

$46M Series B+ ·

Source: casmatx.com

Funding history ↓
Website: casmatx.com.
X: @CasmaTx · 421 followers.
LinkedIn: casma-tx.
Category: Health and bio.
Stage: Series B+.
Last round: Nov 15, 2022 · 1,458 days ago.
On Recent Funding since: Nov 8, 2026.

Signals

X account@CasmaTx · created Apr 19, 2018 (8 years old) · 421 followers
Website registeredDec 5, 2017 (8 years old)
TIMELINE · MONEY RAISED

Casma Therapeutics | 1806 days from website to first raise on record

@CasmaTx·Raised $46M in 1 sourced round·2 signals before the first raise
$12M$23M$34M$46MJAN 2018MARMAYJULSEPNOVJAN 2025MAR$46M||WEBSITE CREATED · DEC 5, 2017||X ACCOUNT CREATED @CASMATX · APR 19, 2018$46M Series B+ · Nov 15, 2022$46M B+ · NOV '22

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

  1. Series B+ · $46M
    Source: casmatx.com
  2. X account created
  3. Website created

Founders and team

Companies like Casma Therapeutics

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/casma-therapeutics (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy